Stocktoria
UTAH MEDICAL PRODUCTS INC UTMD
UTAH MEDICAL PRODUCTS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.5M | $40.9M | $50.2M | $52.3M | $49.1M | $42.2M | $46.9M | $42.0M | $41.4M | $39.3M |
| Gross profit | $22.0M | $24.1M | $30.0M | $32.2M | $30.9M | $25.5M | $29.5M | $26.3M | $26.4M | $23.7M |
| R&D expense | $668,000 | $813,000 | $560,000 | $493,000 | $526,000 | $486,000 | $483,000 | $454,000 | $447,000 | $475,000 |
| Operating income | $11.4M | $13.6M | $16.8M | $19.8M | $18.9M | $13.7M | $17.6M | $18.7M | $19.0M | $16.2M |
| Income tax | $2.8M | $2.9M | $3.5M | $4.2M | $4.3M | $3.0M | $3.2M | $904,000 | $10.6M | $4.3M |
| Operating cash flow | $14.7M | $14.8M | $22.3M | $21.1M | $21.2M | $20.1M | $17.1M | $16.8M | $16.9M | $14.5M |
| Free cash flow | $14.3M | $14.6M | $21.6M | $20.3M | $20.7M | $19.3M | $16.5M | $16.4M | $15.3M | $11.2M |
| Cash & equivalents | $85.8M | $83.0M | $92.9M | $75.1M | $61.0M | $51.6M | $42.8M | $51.1M | $39.9M | $26.3M |
| Inventory | $7.9M | $8.8M | $9.6M | $8.8M | $6.6M | $6.2M | $6.9M | $6.9M | $5.2M | $4.5M |
| Total assets | $122.5M | $122.5M | $135.5M | $123.9M | $115.6M | $111.7M | $109.8M | $99.8M | $92.7M | $76.2M |
| Total liabilities | $3.3M | $5.1M | $7.1M | $9.6M | $8.5M | $8.9M | $8.7M | $10.8M | $14.6M | $6.9M |
| Shareholders' equity | $119.3M | $117.4M | $128.3M | $114.3M | $107.1M | $102.8M | $101.1M | $89.0M | $78.1M | $69.2M |
| EPS (diluted) | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 | $2.94 | $3.94 | $4.95 | $2.28 | $3.22 |
Growth · year-over-year · Revenue CAGR -0.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -5.8% | -18.6% | -3.9% | +6.6% | +16.3% | -10.1% | +11.7% | +1.4% | +5.4% | -2.1% |
| EPS growth | -12.1% | -13.3% | +1.1% | +11.9% | +37.4% | -25.4% | -20.4% | +117.1% | -29.2% | +2.5% |
| Free cash flow growth | -1.9% | -32.5% | +6.4% | -1.5% | +7.1% | +16.7% | +0.5% | +7.3% | +36.3% | -17.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.